middle.news
How Tetratherix’s New Deals and Facility Build Signal a Breakthrough Year Ahead
8:36am on Wednesday 28th of January, 2026 AEDT
•
Healthcare
Read Story
How Tetratherix’s New Deals and Facility Build Signal a Breakthrough Year Ahead
8:36am on Wednesday 28th of January, 2026 AEDT
Key Points
BioOptix partners with Alcon for ophthalmic biomaterials development
Tutelix joint venture advances patient recruitment in interventional urology trial
Bone regeneration products Tegenix and TegenEOS progress towards FDA clearance
Global exclusive distribution deal signed with Henry Schein for Tegenix
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TETRATHERIX (ASX:TTX)
OPEN ARTICLE